Related Experiment Video
Updated: Aug 6, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
Arsenic enhances the apoptosis induced by interferon gamma: key role of IRF-1
J El Bougrini1, M Pampin, M K Chelbi-Alix
1UPR CNRS 9045, Institut André Lwoff 7 rue Guy Moquet, 94801 Villejuif, France.
Abstract:
Interferons (IFNs) and arsenic trioxide (As2O3) are known inhibitors of cell proliferation and have been used in the treatment of certain forms of malignancy. IFNgamma treatment of cells leads to tyrosine phosphorylation of STAT1 followed by dimerization that accumulates in the nucleus. This is followed by DNA binding, activation of target gene transcription, dephosphorylation, and return to the cytoplasm. We have shown earlier that IFNgamma and As2O3 act synergistically in acute promyelocytic leukemia cells to upregulate IRF-1 expression and to induce apoptosis. Here, we show that in the human fibrosarcoma cell line 2fTGH, As2O3 prolongs IFNgamma-induced STAT1 phosphorylation resulting in persistent binding of STAT1 to GAS motif leading to an increase in IRF-1 expression which correlated with both higher anti-proliferative effect and increased apoptosis. These biological responses induced by IFNgamma alone or in combination with As2O3 were abolished when IRF-1 expression was down-regulated by RNA interference, thus demonstrating the key role of IRF-1.
Insights
Interferons (IFNs) and arsenic trioxide synergize to inhibit cancer cell growth. This combination prolongs STAT1 activation, increasing IRF-1 expression, which drives anti-proliferative effects and apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- Interferons (IFNs) and arsenic trioxide (As2O3) are established inhibitors of cell proliferation with applications in malignancy treatment.
- IFNgamma signaling involves STAT1 phosphorylation, dimerization, nuclear translocation, DNA binding, and gene transcription.
Purpose of the Study:
- To investigate the synergistic effects of IFNgamma and As2O3 on STAT1 phosphorylation and IRF-1 expression in human fibrosarcoma cells.
- To elucidate the role of IRF-1 in mediating the anti-proliferative and pro-apoptotic effects of this combination therapy.
Main Methods:
- Utilized the human fibrosarcoma cell line 2fTGH.
- Administered IFNgamma and As2O3, alone and in combination.
- Assessed STAT1 phosphorylation, DNA binding to GAS motifs, IRF-1 expression, cell proliferation, and apoptosis.
- Employed RNA interference to down-regulate IRF-1 expression.
Main Results:
- As2O3 prolonged IFNgamma-induced STAT1 phosphorylation, leading to sustained STAT1 binding to GAS motifs.
- This resulted in significantly increased IRF-1 expression.
- The enhanced IRF-1 expression correlated with increased anti-proliferative effects and apoptosis.
- Down-regulation of IRF-1 abolished the biological responses induced by IFNgamma and As2O3.
Conclusions:
- The combination of IFNgamma and As2O3 exhibits synergistic anti-cancer activity in fibrosarcoma cells.
- Sustained STAT1 activation and subsequent IRF-1 upregulation are critical mediators of these synergistic effects.
- IRF-1 plays a key role in mediating the anti-proliferative and pro-apoptotic outcomes of this therapeutic combination.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Inhibitors of Viral Protein Synthesis
Apoptosis
Caspases
Regulation of the Unfolded Protein Response

